OmniAb, Inc. (OABI)
NASDAQ: OABI · Real-Time Price · USD
2.070
+0.060 (2.99%)
At close: Jan 22, 2026, 4:00 PM EST
2.070
0.00 (0.00%)
After-hours: Jan 22, 2026, 4:00 PM EST
OmniAb Employees
OmniAb had 114 employees as of December 31, 2024. The number of employees increased by 8 or 7.55% compared to the previous year.
Employees
114
Change (1Y)
8
Growth (1Y)
7.55%
Revenue / Employee
$185,035
Profits / Employee
-$558,491
Market Cap
299.43M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 114 | 8 | 7.55% |
| Dec 31, 2023 | 106 | 11 | 11.58% |
| Dec 31, 2022 | 95 | 21 | 28.38% |
| Dec 31, 2021 | 74 | 4 | 5.71% |
| Dec 31, 2020 | 70 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 222 |
| Cabaletta Bio | 164 |
| Nautilus Biotechnology | 155 |
| Abeona Therapeutics | 136 |
| Neurogene | 107 |
| Rezolute | 71 |
| Larimar Therapeutics | 65 |
| Atea Pharmaceuticals | 56 |
OABI News
- 5 weeks ago - OmniAb, Inc. (OABI) Discusses Launch and Scientific Overview of OmniUltra Technology Platform Transcript - Seeking Alpha
- 5 weeks ago - Launch of OmniUltra Expands OmniAb's Reach into New Markets and Applications, Advances Leadership in Antibody Discovery Technologies - Business Wire
- 7 weeks ago - OmniAb to Hold OmniUltra Virtual Investor Event on December 15 - Business Wire
- 2 months ago - OmniAb Enters into a Technology License and Services Agreement for Antibody Discovery with a Newly-Formed Incubated Company of ArrowMark Partners and Viking Global Investors - Business Wire
- 2 months ago - OmniAb, Inc. (OABI) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - OmniAb Reports Third Quarter 2025 Financial Results and Business Highlights - Business Wire
- 3 months ago - OmniAb to Participate in Three Investor Conferences in November - Business Wire
- 3 months ago - OmniAb to Report Third Quarter 2025 Financial Results on November 4 - Business Wire